Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.17 $1.66 Friday, 10th May 2024 IFRX stock ended at $1.18. This is 1.67% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.41% from a day low at $1.17 to a day high of $1.25.
90 days $1.17 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Jan 24, 2024 $1.71 $1.76 $1.60 $1.60 151 095
Jan 23, 2024 $1.65 $1.76 $1.65 $1.72 128 434
Jan 22, 2024 $1.60 $1.67 $1.60 $1.65 41 594
Jan 19, 2024 $1.56 $1.66 $1.56 $1.60 111 877
Jan 18, 2024 $1.61 $1.61 $1.57 $1.60 45 411
Jan 17, 2024 $1.63 $1.64 $1.55 $1.62 114 665
Jan 16, 2024 $1.73 $1.74 $1.64 $1.65 103 197
Jan 12, 2024 $1.76 $1.84 $1.67 $1.73 186 659
Jan 11, 2024 $1.95 $1.95 $1.74 $1.75 514 491
Jan 10, 2024 $2.06 $2.10 $1.94 $1.99 442 131
Jan 09, 2024 $1.93 $2.07 $1.84 $2.03 659 017
Jan 08, 2024 $1.80 $1.91 $1.72 $1.90 412 729
Jan 05, 2024 $1.85 $1.85 $1.70 $1.79 403 650
Jan 04, 2024 $1.69 $1.85 $1.66 $1.83 1 028 551
Jan 03, 2024 $1.64 $1.64 $1.58 $1.60 68 351
Jan 02, 2024 $1.64 $1.73 $1.63 $1.64 126 224
Dec 29, 2023 $1.65 $1.70 $1.56 $1.63 238 426
Dec 28, 2023 $1.85 $1.85 $1.65 $1.66 335 904
Dec 27, 2023 $1.66 $1.84 $1.65 $1.81 376 413
Dec 26, 2023 $1.75 $1.76 $1.68 $1.69 158 347
Dec 22, 2023 $1.45 $1.77 $1.45 $1.71 572 357
Dec 21, 2023 $1.54 $1.54 $1.43 $1.48 358 402
Dec 20, 2023 $1.42 $1.54 $1.41 $1.49 406 052
Dec 19, 2023 $1.40 $1.48 $1.40 $1.45 254 541
Dec 18, 2023 $1.32 $1.43 $1.30 $1.41 372 916
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT